Ligand-independent homo- and heterodimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization.

scientific article published on 23 March 2006

Ligand-independent homo- and heterodimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1210/ME.2005-0291
P698PubMed publication ID16556730
P5875ResearchGate publication ID7222067

P50authorAamer M QaziQ59559946
P2093author name stringChon-Hwa Tsai-Morris
Maria L Dufau
P433issue8
P921main subjectprotein heterodimerization activityQ14762999
P304page(s)1912-1923
P577publication date2006-03-23
P1433published inMolecular EndocrinologyQ3319475
P1476titleLigand-independent homo- and heterodimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization
P478volume20

Reverse relations

cites work (P2860)
Q39770160A combined computational and structural model of the full-length human prolactin receptor
Q36403398A mimic of phosphorylated prolactin induces apoptosis by activating AP-1 and upregulating p21/waf1 in human prostate cancer PC3 cells
Q38237652A new mechanism for growth hormone receptor activation of JAK2, and implications for related cytokine receptors
Q34437651Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies
Q35139926Complex formation and interactions between transcription factors essential for human prolactin receptor gene transcription
Q27650572Crystal structure of a prolactin receptor antagonist bound to the extracellular domain of the prolactin receptor
Q33689038Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells
Q38896557Expression of autocrine prolactin and the short isoform of prolactin receptor are associated with inflammatory response and apoptosis in monocytes stimulated with Mycobacterium bovis proteins.
Q40828550Frontiers commentary on tallet et Al. Investigation of prolactin receptor activation and blockade using time-resolved fluorescence resonance energy transfer
Q38672386Functions of intrinsic disorder in transmembrane proteins.
Q36859543GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR Homodimers
Q30422087Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function
Q34712091Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex
Q33769402Impact of subdomain D1 of the short form S1b of the human prolactin receptor on its inhibitory action on the function of the long form of the receptor induced by prolactin
Q37192090Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor
Q35971094Investigation of prolactin receptor activation and blockade using time-resolved fluorescence resonance energy transfer
Q42286181Linear motifs confer functional diversity onto splice variants
Q37027615Lipopolysaccharide induces the expression of an autocrine prolactin loop enhancing inflammatory response in monocytes.
Q39801736Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacity
Q36574668Mechanisms of JAK/STAT pathway negative regulation by the short coreceptor Eye Transformer/Latran.
Q37349034Mechanisms of transient signaling via short and long prolactin receptor isoforms in female and male sensory neurons.
Q27008904Molecular mechanisms of prolactin and its receptor
Q38381546New insights in prolactin: pathological implications
Q38282713Prolactin (PRL) in adipose tissue: regulation and functions.
Q92539054Prolactin - a pleiotropic factor in health and disease
Q90724936Prolactin Biology and Laboratory Measurement: An Update on Physiology and Current Analytical Issues
Q37237603Prolactin activation of the long form of its cognate receptor causes increased visceral fat and obesity in males as shown in transgenic mice expressing only this receptor subtype
Q34025392Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice
Q53304500Prolactin receptor attenuation induces zinc pool redistribution through ZnT2 and decreases invasion in MDA-MB-453 breast cancer cells.
Q27025466Prolactin receptor in regulation of neuronal excitability and channels
Q37341941Prolactin regulates TRPV1, TRPA1, and TRPM8 in sensory neurons in a sex-dependent manner: Contribution of prolactin receptor to inflammatory pain
Q40000478Prolactin stimulates transepithelial calcium transport and modulates paracellular permselectivity in Caco-2 monolayer: mediation by PKC and ROCK pathways
Q37064937Rational design of competitive prolactin/growth hormone receptor antagonists
Q37060370Regulation of prolactin receptor levels and activity in breast cancer
Q37244649Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor
Q37662281Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells
Q36026383S179D prolactin: antagonistic agony!
Q38785779S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain
Q27664687Structural Characterization of the Stem–Stem Dimerization Interface between Prolactin Receptor Chains Complexed with the Natural Hormone
Q27647816Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL
Q37227315Structure and function of a new class of human prolactin antagonists
Q47699567Subdomain 2, Not the Transmembrane Domain, Determines the Dimerization Partner of Growth Hormone Receptor and Prolactin Receptor
Q89555422The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females
Q36932552The role of prolactin receptor in GH signaling in breast cancer cells
Q35043880Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation
Q37972125Triennial Lactation Symposium: Prolactin: The multifaceted potentiator of mammary growth and function
Q34721567What can we learn from rodents about prolactin in humans?

Search more.